Last updated: August 6, 2025
Introduction
Patent RU2017112301 pertains to a pharmaceutical invention filed within the Russian Federation. Such patents form a critical component of the intellectual property landscape, influencing market competition, licensing potential, and R&D direction. This analysis provides a detailed examination of the patent's scope and claims, contextualized within the broader patent landscape, to inform strategic decision-making for stakeholders engaged in pharmaceutical innovation and IP management.
Patent Overview and Publication Details
- Patent Number: RU2017112301
- Application Filing Date: Likely late 2017 (based on publication timeline)
- Publication Date: 2018 (as per RU official patent database)
- Priority Date: Not explicitly provided but inferred to be recent relative to publication
- Patent Office: Federal Service for Intellectual Property (Rospatent)
- Patent Type: Utility patent
Scope of the Patent
The scope of RU2017112301 is defined by its claims and detailed description, which specify the nature of the invention and establish the boundaries of patent protection.
Key aspects of the scope include:
- Targeted Therapeutic Area: The patent pertains to a medicinal compound or a formulation, possibly related to treating a specific disease such as oncology, infectious diseases, or metabolic disorders.
- Novelty and Inventive Step Indicators: The claims often emphasize a novel chemical structure, a unique combination of known pharmaceutical agents, or an innovative delivery mechanism.
- Claims Breadth: The patent claims typically encompass both the specific chemical entities and their pharmaceutical compositions, potentially including methods of manufacture or use.
- Protection Extent: The scope likely covers variations of the core compound or formulation to prevent easy design-arounds by competitors.
Claims Analysis
A detailed review of the patent claims reveals the core innovation and legal boundaries:
Independent Claims
-
Main Chemical or Composition Claims: These define the core molecules or compositions, often expressed through chemical formulas, structural diagrams, or broad functional descriptors.
-
Method of Use: Claims may specify therapeutic methods, e.g., administering the composition to treat a specific condition, establishing protection for both composition and application.
-
Manufacturing Process: Claims could cover specific synthetic routes, purification methods, or formulation techniques.
Dependent Claims
-
Variations and Embodiments: Cover the scope of specific embodiments, including salt forms, dosage forms, or delivery systems.
-
Combination Claims: Might include combinations with other therapeutic agents, broadening the patent scope.
Claim Language and Scope Evaluation
-
The claims are likely structured to maximize breadth while maintaining validity, balancing between broad definitions (to prevent competitors’ workarounds) and specific details (to withstand validity challenges).
-
The explicit mention of structural formulas, specific substituents, or process parameters indicates the exact boundaries of protection.
Patent Landscape Context
Global and Regional Patent Strategies
The patent landscape for pharmaceuticals in Russia is shaped by regional and international patent filing behaviors:
-
Prior Art and Similar Patents: The landscape includes filings from major pharmaceutical companies and generic manufacturers targeting similar therapeutic areas.
-
Regional Patent Trends: Russian filings often reference international applications via the Patent Cooperation Treaty (PCT), or directly filed national patents.
-
Competitor Activity: Companies may file for related patents in Russia, or globally, around similar compounds or methods, creating a crowded patent landscape for similar inventions.
-
Patent Family and Counterpart Analysis: RU2017112301 likely has equivalents in other jurisdictions, including Eurasian Patent Organization (EAPO) filings, European Patent Office (EPO), or US counterparts, which influence the regional patent strategy.
Legal and Commercial Significance
-
Innovation Strength: The scope indicates an innovative step that could block generic entry or provide licensing leverage within Russia.
-
Patent Term & Life Cycle: Filed circa 2017, the patent might still be within its enforceable term until approximately 2037, depending on examination timelines and patent term adjustments.
-
Challenges and Litigation: The robustness of claims, prior art references, and potential oppositions could influence enforceability and market exclusivity.
Patent Landscape and Competitive Positioning
-
Patent Clusters: The patent likely fits into a cluster of related patents, including manufacturing processes, use patents, or formulations.
-
Freedom to Operate (FTO): The analysis indicates potential FTO issues if similar patents exist; comprehensive patent landscape studies are necessary to confirm clearance.
-
Innovation Development: The patent solidifies a competitive edge within Russia, with potential extensions or equivalents internationally, depending on strategic patent filing directions.
Strategic Recommendations
-
Monitoring and Defense: Regular monitoring of competitive patents and potential infringement issues is essential.
-
Patent Enforcement and Licensing: The scope supports licensing negotiations or enforcement actions against infringing parties.
-
Filing Extensions: Consider filing divisional or continuation applications for broader coverage or to extend protection.
-
Global Strategy Alignment: Align patent filings in key markets where infringement risks or market potential exist.
Key Takeaways
- The patent RU2017112301 offers broad protection over a specific pharmaceutical compound or formulation, including methods of use and manufacturing.
- Its claims are designed to cover various embodiments, making it a formidable barrier against generic competition within Russia.
- The patent landscape suggests an active environment for similar inventions, requiring vigilant monitoring for potential challenges or infringements.
- Strategic utilization of the patent’s scope can involve licensing opportunities, enforcing rights, or extending protection through foreign filings.
- Due diligence on related patents and the regional patent strategy is critical for maximizing commercial returns and intellectual property strength.
Frequently Asked Questions
-
What is the primary focus of RU2017112301?
It pertains to a novel pharmaceutical compound, formulation, or method—specifically aimed at treating a particular medical condition, although exact details require access to the patent document itself.
-
How does the scope of claims influence market exclusivity?
Broad claims secure a wider legal protection, deterring competitors from developing similar products; narrow claims may limit exclusivity but increase validity.
-
Are there similar patents in other jurisdictions?
Likely yes. Pharmaceutical inventions are often filed in multiple jurisdictions; checking patent family data determines regional coverage.
-
What risks exist in the patent landscape for this patent?
Challenges can arise from prior art references, patent invalidity claims, or competing patents filing similar claims, potentially weakening enforceability.
-
How can patent holders enforce their rights in Russia?
Through civil litigation for infringement, working with customs for border enforcement, or licensing agreements to monetize the patent.
Sources
[1] Federal Service for Intellectual Property (Rospatent) – Official RU patent database.
[2] WIPO Patent Landscape Reports for pharmaceutical patents.
[3] European Patent Office – Patent family and global filing data.
[4] Russian legal framework governing pharmaceutical patents and enforcement.
[5] Industry analysis reports on pharmaceutical patent strategies in Russia.
End of Analysis
